阿伐斯汀的最小制剂规格为100mg，而治疗老年黄斑变性（age-related macular degeneration, AMD）的剂量为1 – 2 mg，因此，医生需要将一个单包装100mg的阿伐斯汀分装成近百份小包装，其过程很...
基于8个网页-相关网页
...制及相关药物研究进展 【关键词】老年黄斑变性发病机制光动力学治疗药物治疗老年黄斑变性(Age-relatedmaculardegeneration,AMD)是发达国家50岁以上人群的主要致盲原因，其发病机制复杂…
基于2个网页-相关网页
用于治疗老年黄斑变性 age-related macular degeneration
Genetech公司研制的药物Lucentis被证明能够有效治疗湿性年龄相关性黄斑变性(亦称老年性黄斑变性)，这种眼病可以导致失明。
A drug called Lucentis, made by Genetech, has proved effective at treating the wet form of age-related macular degeneration, which can lead to blindness.
与新细胞的生长有关。某些研究认为它在老年性黄斑变性(amd)治疗中有益处。
Involved in the growth of new cells. Some research suggests a beneficial effect in the treatment of age-related macular degeneration (AMD).
目的探讨老年性黄斑变性放射治疗的临床意义。
Objective To investigate the clinical significance of radiotherapy of senile macular degeneration.
应用推荐